Atlantic Bone Screen is a specialized preclinical CRO with recognized expertise in bone and joint health, as well as oncology.

They provide both in vitro and in vivo non-GLP evaluations of drug candidates, supporting the demonstration of product efficacy in comparison with standard of care or competitor products.

Atlantic Bone Screen’s capabilities include:
• In vitro models using tumor cell lines, macrophages, chondrocytes, osteoblasts and osteoclasts, as well as keratinocytes, fibroblasts, and skin explants
• In vivo models in rats and mice, including both chemically and surgically induced pathologies, supported by their in-house animal facility